ポイントオブケア (POC) 診断向けポリメラーゼ連鎖反応 (PCR)

世界のポイントオブケア (POC) 診断向けポリメラーゼ連鎖反応 (PCR) の市場規模は、2024年の16億米ドルから、予測期間中はCAGR 5.9%で推移し、2029年末には21億米ドルに達すると予測されています。

消耗品の部門は、2024年の12億米ドルから、CAGR 6.1％で推移し、2029年末には16億米ドルに達すると予測されています。また、分析装置の部門は、2024年の3億6,010万米ドルから、CAGR 5.3%で推移し、2029年末には4億6,550万米ドルに達すると予測されています。

市場区分：

製品タイプ別：

• 分析装置
• 消耗品

分析対象別：

• POC PCR分析装置：
• 単一分析対象
• 複数分析対象
• 消耗品：
• 単一分析対象
• 複数分析対象

用途別：

• 感染症
• 性感染症 (STI)
• その他の疾患

当レポートでは、世界のポイントオブケア (POC) 診断向けポリメラーゼ連鎖反応 (PCR) の市場を調査し、市場概要、市場影響因子および市場機会の分析、新興技術および技術開発の動向、特許動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• ポリメラーゼ連鎖反応 (PCR) 技術
• ポイントオブケア (POC) PCRシステムおよびアッセイ

第3章 市場力学

• 市場力学：スナップショット
• 市場促進要因
• 市場機会
• 市場抑制要因
• 市場の課題

第4章 新興技術と開発

• 概要
• 器具不要のPCR検査
• 5分間のPOC検査
• スマートフォン対応PCRシステム
• 特許
• 主要特許

第5章 PCR POC診断の世界市場

• セグメント内訳
• 市場内訳：製品タイプ別
• 市場内訳：分析対象別
• 分析装置：分析対象物別
• 消耗品：分析対象物別
• 市場内訳：用途別
• 感染症
• 性感染症
• 地理的内訳
• 市場内訳：地域別
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 業界シナリオ
• 企業シェア
• 企業間の競合情勢
• POC PCR分析装置の競合情勢
• POC PCR消耗品の競合情勢

第7章 ポイントオブケア (POC) 診断向けポリメラーゼ連鎖反応 (PCR) 市場における持続可能性：ESGの観点

• ESG：イントロダクション
• POC PCR市場の持続可能性：ESGの観点
• 主要なESG上の問題
• ESGパフォーマンス分析
• BCCによる総論

第8章 付録

• 調査手法
• 頭字語
• 参考文献
• 企業プロファイル
• ABBOTT
• CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• QIAGEN
• QUANTUMDX GROUP LTD.
• THERMO FISHER SCIENTIFIC INC.
• VISBY MEDICAL INC.

List of Tables

• Summary Table : Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, Through 2029
• Table 1 : Global HIV Infections, 2022
• Table 2 : People Living with HIV, by Region, 2022
• Table 3 : Global Incidence of All Cancers, by Region, 2022-2050
• Table 4 : Global Incidence of Leukemia, by Region, 2022-2050
• Table 5 : Global Incidence of Hodgkin Lymphoma, by Region, 2022-2050
• Table 6 : Global Incidence of Non-Hodgkin Lymphoma, by Region, 2022-2050
• Table 7 : Global Incidence of Multiple Myeloma, by Region, 2022-2050
• Table 8 : Selected Patents on PCR POC Technology, 2015-Present
• Table 9 : Global Market for PCR POC Diagnostics, Through 2029
• Table 10 : Global Market for PCR POC Diagnostics, by Product Type, Through 2029
• Table 11 : Global Market for PCR POC Analyzers, by Analyte, Through 2029
• Table 12 : Global Market for Single Analyte PCR POC Analyzers, by Region, Through 2029
• Table 13 : Global Market for Multi-Analyte PCR POC Analyzers , by Region, Through 2029
• Table 14 : Global Market for PCR POC Consumables, by Analyte, Through 2029
• Table 15 : Global Market for Single Analyte PCR POC Consumables, by Region, Through 2029
• Table 16 : Global Market for Multi-Analyte PCR POC Consumables, by Region, Through 2029
• Table 17 : Global Market for PCR for POC Diagnostics, by Application, Through 2029
• Table 18 : Global Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
• Table 19 : Global Market for PCR POC Diagnostics in Infectious Diseases, by Region, Through 2029
• Table 20 : North American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
• Table 21 : North American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
• Table 22 : Latin American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
• Table 23 : Latin American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
• Table 24 : European Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
• Table 25 : European Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
• Table 26 : Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
• Table 27 : Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
• Table 28 : RoW Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
• Table 29 : Global Market for PCR POC Diagnostics in STIs, Through 2029
• Table 30 : Global Market for PCR POC Diagnostics in STIs, by Region, Through 2029
• Table 31 : North American Market for PCR POC Diagnostics in STIs, Through 2029
• Table 32 : North American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
• Table 33 : Latin American Market for PCR POC Diagnostics in STIs, Through 2029
• Table 34 : Latin American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
• Table 35 : European Market for PCR POC Diagnostics in STIs, Through 2029
• Table 36 : European Market for PCR POC Diagnostics in STIs, by Country, Through 2029
• Table 37 : Asia-Pacific Market for PCR POC Diagnostics in STIs, Through 2029
• Table 38 : Asia-Pacific Market for PCR POC Diagnostics in STIs, by Country, Through 2029
• Table 39 : RoW Market for PCR POC Diagnostics in STIs, Through 2029
• Table 40 : Global Market for PCR for POC Diagnostics, by Region, Through 2029
• Table 41 : North American Market for PCR POC Diagnostics, by Product Type, Through 2029
• Table 42 : North American Market for PCR POC Diagnostics, by Country, Through 2029
• Table 43 : Latin American Market for PCR POC Diagnostics, by Product Type, Through 2029
• Table 44 : Latin American Market for PCR POC Diagnostics, by Country, Through 2029
• Table 45 : European Market for PCR POC Diagnostics, by Product Type, Through 2029
• Table 46 : European Market for PCR POC Diagnostics, by Country, Through 2029
• Table 47 : Asia-Pacific Market for PCR POC Diagnostics, by Product Type, Through 2029
• Table 48 : Asia-Pacific Market for PCR POC Diagnostics, by Country, Through 2029
• Table 49 : RoW Market for PCR POC Diagnostics, by Product Type, Through 2029
• Table 50 : ESG: Environmental Overview
• Table 51 : ESG: Social Overview
• Table 52 : ESG: Governance Overview
• Table 53 : ESG Rankings for Polymerase Chain Reaction Point-of-Care Diagnostics Companies, 2023*
• Table 54 : Acronyms Used in This Report
• Table 55 : Abbott: Company Snapshot
• Table 56 : Abbott: Financial Performance, 2022 and 2023
• Table 57 : Abbott: Product Portfolio
• Table 58 : Abbott: News/Key Developments, 2022
• Table 59 : Credo Diagnostics Biomedical Pte. Ltd.: Company Snapshot
• Table 60 : Credo Diagnostics Biomedical Pte. Ltd.: Product Portfolio
• Table 61 : Credo Diagnostics Biomedical Pte. Ltd.: News/Key Developments, 2022
• Table 62 : Danaher Corp.: Company Snapshot
• Table 63 : Danaher Corp.: Financial Performance, FY 2022 and 2023
• Table 64 : Danaher Corp.: Product Portfolio
• Table 65 : Danaher Corp.: News/Key Developments, 2023 and 2024
• Table 66 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 67 : F. Hoffmann-La Roche Ltd.: Financial Performance, 2022 and 2023
• Table 68 : F. Hoffmann-La Roche Ltd.: Product Portfolio
• Table 69 : QIAGEN: Company Snapshot
• Table 70 : QIAGEN: Financial Performance, FY 2022 and 2023
• Table 71 : QIAGEN: Product Portfolio
• Table 72 : QIAGEN: News/Key Developments, 2022
• Table 73 : Quantumdx Group Ltd.: Company Snapshot
• Table 74 : Quantumdx Group Ltd.: Product Portfolio
• Table 75 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 76 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 77 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 78 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021
• Table 79 : Visby Medical Inc.: Company Snapshot
• Table 80 : Visby Medical Inc.: Product Portfolio
• Table 81 : Visby Medical Inc.: News/Key Developments, 2023

List of Figures

• Summary Figure A : Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2021-2029
• Summary Figure B : Global Market Shares of Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2023
• Figure 1 : Polymerase Chain Reaction for Point of Care Diagnostics: Market Dynamics
• Figure 2 : Emerging Trends and Technologies in PCR for POC Diagnostics
• Figure 3 : Global Market Shares of PCR POC Diagnostics, by Company, 2023
• Figure 4 : Global Market Shares of POC PCR Analyzers, by Company, 2023
• Figure 5 : Global Market Shares of POC PCR Consumables, by Company, 2023
• Figure 6 : ESG Pillars
• Figure 7 : Advantages of ESG for Companies
• Figure 8 : Share of ESG Penetration in Polymerase Chain Reaction POC Diagnostics Market, 2023
• Figure 9 : Abbott: Revenue Share, by Business Unit, 2023
• Figure 10 : Abbott: Revenue Share, by Country/Region, 2023
• Figure 11 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 12 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 13 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 14 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 15 : QIAGEN: Revenue Share, by Business Unit, FY 2023
• Figure 16 : QIAGEN: Revenue Share, by Country/Region, FY 2023
• Figure 17 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 18 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

The global market for PCR POC consumables is expected to grow from $1.2 billion in 2024 to $1.6 billion by the end of 2029, at a CAGR of 6.1% from 2024 through 2029.

The global market for PCR POC analyzers is expected to grow from $360.1 million in 2024 to $465.5 million by the end of 2029, at a CAGR of 5.3% from 2024 through 2029.

Report Scope

This report provides a comprehensive summary of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with a detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current and potential market size. It will enable market players and new entrants to make informed decisions regarding the production and licensing of goods and services. Organizations, distributors and exporters should find useful information regarding market development and trends. The study segments the market on the basis of product type, such as POC PCR analyzers, consumables, single analyte, multi-analyte and applications. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.

The market is divided into segments and by application/industry:

By Product type:

• POC PCR analyzers.
• Consumables.

By analyte:

• POC PCR analyzers.
• Single analyte.
• Multi-analyte.
• Consumables.
• Single analyte.
• Multi-analyte.

By Application:

• Infectious diseases.
• Sexually transmitted diseases (STIs).
• Other diseases.

Each area is covered in detail, identifying current products in the market in the base year (2023), measuring the current market size and identifying current and potential market drivers, forecasting for 2029, assessing current and potential competitors, and identifying current competitor market shares for 2023.

Report Includes

• 53 data tables and 29 additional tables
• An overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with an evaluation of each market segment's future commercial potential
• Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Evaluation of the current market size and revenue growth prospects, along with a market share analysis by product, analyte, application and region
• Identification of emerging market opportunities, technology trends and issues, and regulatory frameworks pertaining to PCR technology
• A look at the competitive landscape, including an analysis of the impact of COVID-19 as well as the FDA's contribution to COVID-19 diagnostic testing
• A review of patents and new developments in PCR POC technologies
• Profiles of leading market participants, including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Polymerase Chain Reaction Technology
• Point of Care PCR Systems and Assays

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Market Opportunities
• Market Restraints
• Market Challenges

Chapter 4 Emerging Technologies and Developments

• Overview
• Instrument-Free PCR Tests
• Five-Minute Point-of-Care Testing
• Smartphone Enabled PCR System
• Patents
• Selected Patents

Chapter 5 Global Market for PCR POC Diagnostics

• Segmentation Breakdown
• Market Breakdown by Product Type
• Market Breakdown by Analyte
• PCR POC Analyzers by Analyte
• PCR POC Consumables by Analyte
• Market Breakdown by Application
• Infectious Diseases
• STIs
• Geographic Breakdown
• Market Breakdown by Region
• North America
• Latin America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Industry Scenario
• Company Shares
• Competitive Landscape Among Companies
• Competitive Landscape in POC PCR Analyzers
• Competitive Landscape in POC PCR Consumables

Chapter 7 Sustainability in the Market for Polymerase Chain Reaction for Point of Care Diagnostics: An ESG Perspective

• Introduction to ESG
• Sustainability in Polymerase Chain Reaction for Point-of-Care Diagnostic Industry: An ESG Perspective
• Key ESG Issues
• ESG Performance Analysis
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Research Methodology
• Acronyms
• References
• Company Profiles
• ABBOTT
• CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• QIAGEN
• QUANTUMDX GROUP LTD.
• THERMO FISHER SCIENTIFIC INC.
• VISBY MEDICAL INC.